Needham Downgrades Heron Therapeutics (HRTX) to Hold

June 2, 2026 4:00 PM

Needham analyst Serge Belanger downgraded Heron Therapeutics (NASDAQ: HRTX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found